Feitosa Marley Ribeiro, Parra Rogério Serafim, de Camargo Hugo Parra, Ferreira Sandro da Costa, Troncon Luiz Ernesto de Almeida, da Rocha José Joaquim Ribeiro, Féres Omar
Department of Surgery and Anatomy (Marley Ribeiro Feitosa, Rogério Serafim Parra, Hugo Parra de Camargo, José Joaquim Ribeiro da Rocha, Omar Féres).
Department of Clinical Medicine (Sandro da Costa Ferreira, Luiz Ernesto de Almeida Troncon), Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, State of São Paulo, Brazil.
Ann Gastroenterol. 2021;34(1):39-45. doi: 10.20524/aog.2020.0558. Epub 2020 Nov 26.
COVID-19 has affected the entire world. We aimed to determine the impact of COVID-19 containment measures on the daily life and follow up of patients with inflammatory bowel disease (IBD).
During May 2020, we evaluated 179 (79.6%) patients with Crohn's disease (CD) and 46 (20.4%) with ulcerative colitis (UC) by telephone, using a structured questionnaire to gather information on social impact and IBD follow up.
Some kind of social distancing measure was reported by 95.6% of our patients, self-quarantine (64.9%) being the most frequent. Depressive mood was the most prevalent social impact (80.2%), followed by anxiety/fear of death (58.2%), insomnia (51.4%), daily activity impairment (48%), sexual dysfunction (46.2%), and productivity impairment (44%). The results were similar when we compared patients with active disease to those in remission and patients with UC to those with CD. Analysis of IBD follow up showed that 83.1% of all patients missed an IBD medical appointment, 45.5% of the patients missed laboratory tests, 41.3% missed the national flu vaccination program, 31.3% missed any radiologic exam, 17.3% missed colonoscopy, and 16.9% failed to obtain biologic therapy prescriptions. Biologics were discontinued by 28.4% of the patients. UC patients had higher rates of missed vaccination than CD patients (56.5% vs. 37.4%, P=0.02) and more failures to obtain a biologic prescription (28.3% vs. 14.0%, P=0.02).
Our study reveals alarming social impacts and declining follow-up care for IBD patients during the COVID-19 outbreak. These findings may have implications for disease control in the near future.
新型冠状病毒肺炎(COVID-19)已影响全球。我们旨在确定COVID-19防控措施对炎症性肠病(IBD)患者日常生活及随访的影响。
2020年5月,我们通过电话对179例(79.6%)克罗恩病(CD)患者和46例(20.4%)溃疡性结肠炎(UC)患者进行了评估,使用结构化问卷收集有关社会影响和IBD随访的信息。
95.6%的患者报告采取了某种社交距离措施,其中自我隔离最为常见(64.9%)。抑郁情绪是最普遍的社会影响(80.2%),其次是焦虑/对死亡的恐惧(58.2%)、失眠(51.4%)、日常活动受限(48%)、性功能障碍(46.2%)和工作效率受损(44%)。将活动期疾病患者与缓解期患者以及UC患者与CD患者进行比较时,结果相似。IBD随访分析显示,83.1%的患者错过了IBD医疗预约,45.5%的患者错过了实验室检查,41.3%的患者错过了国家流感疫苗接种计划,31.3%的患者错过了任何影像学检查,17.3%的患者错过了结肠镜检查,16.9%的患者未能获得生物治疗处方。28.4%的患者停用了生物制剂。UC患者错过疫苗接种的比例高于CD患者(56.5%对37.4%,P=0.02),未能获得生物制剂处方的比例也更高(28.3%对14.0%,P=0.02)。
我们的研究揭示了COVID-19疫情期间IBD患者令人担忧的社会影响以及随访护理的下降。这些发现可能对近期的疾病控制产生影响。